CGEM
Cullinan Therapeutics, Inc. · Healthcare
Director and 10% owner Ansbert Gadicke sold $1.5M of Cullinan Therapeutics, Inc.
Sold$1,476,135
$29.24Price
50,489Shares
−1%Stake
What CGEM did after the filing
- The stock from Tue, Aug 31 close, $28.22
- −17.9%
- S&P 500, same days
- −3.3%
Measured over 30 trading days, to the Oct 13 close.
Traded Fri, Aug 27. Filed Tue, Aug 31, 12:48 PM ET, during the session. Returns use the Aug 31 close and the Oct 13 close. Not investment advice.